Cancer treatment with chemotherapeutic agents is often associated with delayed adverse neurological consequences - an occurrence often referred to as “chemobrain” - that may compromise the quality of life of a proportion of cancer survivors.

There exists a direct relationship between the consumption of MDMA, or Ecstasy, at a high ambient temperature and an increase in the neural damage which this drug provokes. This was the conclusion of the research carried out by Beatriz Goñi at the School of Pharmacy of the University of Navarra.